Precigen (PGEN) Minority Interest (2013 - 2025)

Precigen (PGEN) posted quarterly Minority Interest of $30.9 million for Q2 2025, up 4.62% quarter-over-quarter from $29.5 million in Q1 2025.

Precigen (PGEN) Minority Interest (2013 - 2025) Analysis & Trends

Precigen (PGEN) has reported Minority Interest for 9 consecutive years, with $30.9 million the latest figure, recorded in Q2 2025.

In Q2 2025, Minority Interest changed N/A year-over-year to $30.9 million; the TTM figure through Jun 2025 stood at $30.9 million (changed N/A YoY), while the FY2024 annual figure was $28.2 million, changed N/A from the prior year.
Minority Interest advanced to $30.9 million in Q2 2025 per PGEN's latest filing, from $29.5 million in the prior quarter.
Across five years, Minority Interest topped out at $30.9 million in Q2 2025 and bottomed at $28.2 million in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn
10	Precigen	2.18 Bn	2.18 Bn	52.17 Mn

Download Data